FindTrial
Sign In

Superobese Patients

Predictive Factoris of Failure in Superobese Patients Undergoing Bariatric Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05446246
Enrollment
200
Registered
2022-07-06
Start date
2018-01-01
Completion date
2022-09-30
Last updated
2022-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

Super obesity (SO) is defined as a Body Mass Index (BMI) \> 50 kg/m2, and represents the extreme severity of the disease, resulting in an increase in morbidity, mortality, and in poorer quality of life compared with morbid obesity (BMI \> 35 and \<50 kg/m2).

Interventions

PROCEDUREBariatric surgery

Sleeve gastrectomy

Sponsors

University of Cagliari
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Morbid and superobese patients

Exclusion criteria

* Follow up not completed

Design outcomes

Primary

MeasureTime frameDescription
Surgical success24 monthsBMI \<35

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026